27N0.XETRA Cannovum Cannabis AG
- Market cap
- EUR 1.07M
- P/E
- -
- P/B
- 5.37x
- ROE
- -132.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 27N0.XETRA undervalued?
Graham numberThe Graham number of Cannovum Cannabis AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cannovum Cannabis AG fundamental analysis
No fundamental analysis for Cannovum Cannabis AG yet.
Cannovum Cannabis AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cannovum Cannabis AG
Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin. It also focuses on the import of medical cannabis and medical-scientific education, as well as distribution for facilitated access to cannabis-based therapies. The company was formerly known as Cannovum AG and changed its name to Cannovum Cannabis AG in April 2023. Cannovum Cannabis AG was incorporated in 2018 and is based in Berlin, Germany.
Full company profileCannovum Cannabis AG financial statements
Cannovum Cannabis AG annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 5.62K | 3.53K | 0.00 | 3.99K | 0.00 | - |
| Gross Profit | 4.03K | -10.2K | -10.0K | 3.99K | -29.0K | 12.0K |
| Operating Income | 4.03K | -10.2K | -9.82M | -3.03M | -401K | -356K |
| EBITDA | - | -108K | -10.0K | -62.6K | -401K | -356K |
| Net Income | -30.6K | -108K | -9.92M | -3.17M | -401K | -356K |
| EPS | -0.07 | -0.19 | -16 | -1.85 | -0.17 | -0.15 |
| Balance Sheet | ||||||
| Total Assets | 10.7M | 11.6M | 2.67M | 408K | 912K | 441K |
| Total Liabilities | 14.1K | 33.7K | 281K | 272K | 288K | 173K |
| Shareholders' Equity | 10.7M | 11.6M | 2.39M | 136K | 624K | 268K |
| Cash Flow | ||||||
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Ratios | ||||||
| ROE | -0.3% | -0.9% | -414.9% | -2,327.0% | -64.4% | -132.6% |
| ROA | -0.3% | -0.9% | -371.4% | -776.8% | -44.0% | -80.7% |
| Net Profit Margin | -544.0% | -3,060.9% | - | -79,489.1% | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Cannovum Cannabis AG dividends
Cannovum Cannabis AG has not paid dividends in the last 6 fiscal years.
Last stock split: 1:5 on Dec 11, 2023.
Who owns Cannovum Cannabis AG
Ownership data of Cannovum Cannabis AG is not available yet.
Cannovum Cannabis AG company profile
- Company name
- Cannovum Cannabis AG
- Ticker
- 27N0.XETRA
- Exchange
- XETRA Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Fiscal year end
- December
- Address
- Rheinsberger Street 76/77, Berlin, Germany, 10115
- Phone
- 49 303 9821 6360
- Website
- cannovum.com
About Cannovum Cannabis AG
Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin. It also focuses on the import of medical cannabis and medical-scientific education, as well as distribution for facilitated access to cannabis-based therapies. The company was formerly known as Cannovum AG and changed its name to Cannovum Cannabis AG in April 2023. Cannovum Cannabis AG was incorporated in 2018 and is based in Berlin, Germany.
Cannovum Cannabis AG management
5- Ms. Pia MartenCo-Founder, CEO & Member of Management Board
- Mr. Marius KooseCo-Founder
- Dr. Paul WeberHead of Sales
- Dr. Timo KinderHead of Quality Assurance
- Mr. Klaus MadziaC.M.O.